A clinical study to investigate the pharmacokinetic-pharmacodynamic model of propofol after intravenous administration of propofol in children patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000521

Enrollment

Registered

2012-09-04

Start date

2009-03-09

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : propofol intravenous infusion blood sampling(propofol start 0,1,2,3,5,10 minutes, propofol end 0,5,10,20,30,60 minutes)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American society anesthesiologists 1 or 2 body mass index > 16 or < 21

Exclusion criteria

Exclusion criteria: cardiovascular, respiratory, central nervous, kidney disease hypersensitivity history of propofol

Design outcomes

Primary

Measure	Time frame
plasm concentration	—

Secondary

Measure	Time frame
bispectral index	—

Countries

Korea, Republic of

Contacts

Public ContactHee-Soo Kim

Seoul National University Hospital

dami0605@snu.ac.kr+82-2-2072-3659

Outcome results